Jeffrey Chen

TB Research Scientist - Principal Investigator @VIDOInterVac @Usask Also on - all views, opinions and comments are my own

[Jeffrey Chen @JeffChenMycoLab]

@OmarHalfawy Congratulations Omar! Fantastic news!

[Jeffrey Chen @JeffChenMycoLab]

@mbehr_mcgill @PNASNews @vido Correction: @VIDOInterVac

[Jeffrey Chen @JeffChenMycoLab]

@mbehr_mcgill @PNASNews Congrats to Sarah and you 👏🎉🍻Glad the team @VIDO could assist

[Marcel Behr @mbehr_mcgill]

Excited to see the PhD work led by Sarah Danchuk published today at @PNASNews . Virulence hierarchies within the Mycobacterium tuberculosis complex. Thanks to all the authors and collaborators, and especially kudos to Sarah: https://t.co/mNTbRuvW0F. .

[Environment Canada @environmentca]

When food is wasted, so are the resources used to produce it, including #water, energy, and labour. Minimize what you throw away.

Explore #FoodWaste prevention tips: https://t.co/nACmUElRuF

@CEMonthCanada @CircularOnline

[Razia Aliani @RaziaAliani]

We're about to create the 1st gen of scientists who can't research without AI. And honestly? I'm not sure if that's evolution or devolution!

𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝘀𝘁𝘀 𝗮𝗿𝗲 𝗻𝗼𝘄 𝘂𝘀𝗶𝗻𝗴 𝗖𝗵𝗮𝘁𝗚𝗣𝗧 𝘁𝗼:

— Extract key findings from dense papers in seconds
— Design entire experiments from scratch
— Turn complex studies into engaging content for public
— Generate survey questionnaires that would take days to create
— Respond to peer reviewers (yes, really)

& this book does a great job going through these details!

But missed the elephant in the room:
⤴️ research inequality.

Universities with AI access will accelerate faster than those without. Researchers fluent in prompt engineering will outpace those who aren't.

We're creating new divides in an already unequal system!

It doesn't address how AI might bias research directions:
⤴️ We're training AI on biased research. Now it's teaching us. See the problem?

Overall, this isn't another "AI will save us all" book.
Authors actually tested ChatGPT on real research tasks & documented both the wins and the spectacular failures.

𝐌𝐲 𝐭𝐚𝐤𝐞𝐚𝐰𝐚𝐲: We need AI-literate researchers, not AI-dependent ones!

💬 𝗪𝗵𝗶𝗰𝗵 𝗮𝗿𝗲 𝘄𝗲 𝗰𝗿𝗲𝗮𝘁𝗶𝗻𝗴?
Comment if you'd like a link to download this book!
-------------------------

Useful find? Pass it on!
🔄 Retweet

👋 I’m @RaziaAliani
Click my name + follow + 🔔
I post about AI in #research & #analysis

Want FREE tips on using AI in research?
↳ Join 15K+ researchers:
🔗 link in bio
-----------------------

#aiinresearch

[Jeffrey Chen @JeffChenMycoLab]

In doing so, this talented young scientist discovered 1) a novel activator of ESX-1 gene transcription and 2) a novel vaccine that is as protective as BCG but does not compromise existing TB diagnostic tests.

[Jeffrey Chen @JeffChenMycoLab]

Delighted to share our report in Microbiology Spectrum.
Slim Zriba (PhD student) engineered Mycobacterium smegmatis to produce a functional Mtb ESX-1 system.
https://t.co/6m5jnmI0gz

[npj Antimicrobials and Resistance @npjAMR]

A potential antimicrobial treatment for Mycobacterium tuberculosis from a repurposed drug:

https://t.co/J6B05Ihmdu

[VIDO @VIDOInterVac]

VIDO is building a new animal housing facility that will expand our research capacity—housing everything from mosquitoes to ticks to bats🦟🕷️🦇. These vectors are crucial for disease spread, and access to them will help us better prepare for emerging threats. #VIDOis50

[VIDO @VIDOInterVac]

New TB research! 🧫 A collab between VIDO & UBC shows the Parkinson’s drug benztropine may help immune cells fight TB. VIDO confirmed it works in infected mice using our CL3 labs. Great example of shared expertise in action.
🔗 https://t.co/sLcAMuzk4c
#TBResearch #usask #ubc

[Yossef Av-Gay @yossiavgay]

Thank you @UBCNews for highlighting our research. @henok_sahile @UBCMicroImmuno @VIDOInterVac

https://t.co/ihzLF2Lix6

[Jeffrey Chen @JeffChenMycoLab]

@yossiavgay @UBCNews @henok_sahile @UBCMicroImmuno @VIDOInterVac Glad our lab @VIDOInterVac could contribute to this exciting work 👍

[VIDO @VIDOInterVac]

In 50 days, VIDO will celebrate its 50th anniversary!! 🎉 Follow along as we count down by sharing a daily fact about VIDO’s evolution and innovations over the past five decades! #VIDOis50

[Yossef Av-Gay @yossiavgay]

Our paper is out! The Parkinson’s drug benztropine possesses histamine receptor 1-dependent host-directed antimicrobial activity against Mycobacterium tuberculosis. Thanks @henok_sahile and team for your great work. #repurposing @UBC #TB #HDT https://t.co/vXIsuuj23G

[Shekhar lab @sshekhr]

A must read for young scientists!

A career in science requires a thick skin.

https://t.co/qT0cj1fRzW

[International Society for Vaccines (ISV) @Int_S_Vaccines]

📣We have decided to extend the application deadline for LMIC and non-LMIC awards to April 7th!

Please help us spread the word and share the updated flyers within your networks on social media?

Applications can be submitted via the ISV Congress website

https://t.co/TuyHmx85QG

[Canada's CPHO @CPHO_Canada]

Eliminating tuberculosis in Canada IS within reach if we work together. Read our statement for #WorldTBDay to learn how we are working with Indigenous and government partners to achieve this goal: https://t.co/HSWNFM9hN8

[Results Canada @ResultsCda]

This #WorldTBDay, we stand in solidarity with the millions who are affected or lose their lives because of tuberculosis every year.

The effort to #EndTB is urgent. Global health budgets are being cut around the world and TB rates right here in Canada are rising.

Thanks to our volunteers, a record ✨51 monuments📷 will be lit up in red TODAY in every province to raise awareness for TB. These lights serve as a call-to-action for decision-makers to take action to eradicate TB at home and abroad.

Plan an outing tonight to a monument near you to help shine a 📷https://t.co/LArD7zGCwq…

Show up and show your support! #YesWeCanEndTB

[ERA4TB Project @IMI_ERA4TB]

Our @unizar colleagues, Ainhoa, Cris and Santi, were on TV today for #WorldTBDay2025 discussing publications on new compounds, the Hollow Fibre system, integration of AI in clinical trials and the upcoming public plenaries at our general assembly in May!